Merck & Co.’s MSD inaugurated a new Hitec City technology centre spanning digital, data, analytics, AI and engineering functions for its global Human Health business, a move Telangana’s IT minister framed as part of a deliberate two-year push to shift the state’s life-sciences ecosystem from manufacturing scale toward discovery, R&D and global capability creation.
MSD — the trade name used by Merck & Co. outside the United States and Canada — inaugurated a new 2.5-lakh-square-foot Technology Centre in Hyderabad’s Hitec City this week, formally opened by Telangana IT and Industries Minister D. Sridhar Babu. The centre brings together digital, data, analytics, artificial intelligence and engineering capabilities supporting MSD’s global Human Health business, and forms part of the company’s worldwide technology network rather than a standalone regional outpost.
The company has disclosed the centre’s floor area and functional scope but not its planned headcount, investment figure or hiring timetable, so the announcement is, in scale terms, a workplace and capability expansion rather than a research result or a new medicine launch. Its significance lies less in the square footage than in which functions Hyderabad has been chosen to own: software and platform engineering, data and analytics, AI and enterprise technology solutions supporting a global pharmaceutical business, rather than back-office or purely operational work.
Part of a broader pattern
Sridhar Babu situated the MSD opening within a two-year state strategy of moving Telangana’s life-sciences ecosystem — which already spans more than 2,000 companies across APIs, bulk drugs, generics, contract development and manufacturing (CDMO), vaccines and clinical research — from manufacturing scale toward “the next generation of discovery, innovation, advanced R&D and global capability creation.” The minister noted the state’s ambition to reach 100 global capability centres (GCCs), building on more than 75 established in the past year, and referenced Telangana’s Next-Gen Life Sciences Policy 2026–30 as the framework intended to bring the full life-sciences value chain, from discovery through manufacturing, into the state.
The MSD centre is one of several such technology and capability-centre announcements Hyderabad has attracted through 2025 and 2026, spanning both life-sciences-adjacent and unrelated sectors — a pattern consistent with the city’s positioning as a preferred GCC location for global corporations more broadly, independent of any single industry.
Why it matters
For Telangana, the significance is less about MSD specifically and more about what the centre represents: a global biopharmaceutical leader choosing to locate digital, data and AI capability — rather than only manufacturing or clinical operations — in Hyderabad, at a moment when the state is explicitly trying to shift its life-sciences identity away from being primarily a manufacturing and generics hub. Whether this translates into meaningfully expanded local hiring, skills transfer, and knock-on investment by MSD’s supply chain and partner ecosystem — rather than simply another GCC announcement — will depend on details the company has not yet disclosed.
Rashmi Kumari
Key facts
- MSD (Merck & Co.) inaugurated a 2.5-lakh sq ft Technology Centre in Hitec City, Hyderabad, this week
- Centre covers digital, data, analytics, AI and engineering, supporting MSD’s global Human Health business
- Inaugurated by Telangana IT & Industries Minister D. Sridhar Babu; investment and headcount not disclosed
- Positioned within Telangana’s stated two-year push to move its 2,000+ company life-sciences ecosystem from manufacturing scale toward discovery and R&D, under the state’s Next-Gen Life Sciences Policy 2026–30
